Sabrina Runbeck Business Logo in PNG

The Provider’s Edge

Increase Productivity Increase Profit

I didn’t go into medicine to be a cardiac surgeon with Dr. Thomas MacGillivray

I didn’t go into medicine to be a cardiac surgeon with Dr. Thomas MacGillivray
WED, 01 JUL 2020 00:00:00 -0500 ◦ 38 MINUTES
Dr. Thomas E. MacGillivray, MD is a national top cardiothoracic surgeon currently working at Houston Methodist Hospital, the DeBakey Heart & Vascular center as the Chief of Cardiac Surgery and Thoracic Transplant Surgery, as well as the Jimmy Howell Endowed Chair in Cardiovascular Surgery. Previously, he was Co-Director of the Thoracic Aortic Center and Surgical Director of the Adult Congenital Heart Disease Program at Massachusetts General Hospital in Boston. Dr. MacGillivray currently serves as the Society’s Treasurer-Elect; he previously was Chair of the Council on Education and Member Service for the Society of Thoracic Surgery.

If you want to connect with Dr. MacGillivray visit https://www.houstonmethodist.org/heart-vascular/

Are you a busy and ambitious healthcare professional who is looking to advance in your career without feeling overwhelmed, undervalued, or underappreciated? Then sign up for our FREE 7-days online summit.
Reserve your seat at SabrinaRunbeck.com/summit

Have a topic or question you'd like to see covered on the show? Send an email to Sabrina@SabrinaRunbeck.com or message Sabrina on Instagram, Facebook, or LinkedIn @SabrinaRunbeck.

Recent Post

What Signals Tell Investors a HealthTech Company Is Built for the Long Term?

By Sabrina | 01/18/2026
What Signals Tell Investors a HealthTech Company Is Built for the Long Term? Investors look for long-term healthtech winners by ... Read More

Why Raising Capital Isn’t About the Pitch—And What Investors Evaluate Instead

By Sabrina | 01/18/2026
Why Raising Capital Isn't About the Pitch And What Investors Evaluate Instead If investors say they love your vision but ... Read More

How Smart Founders Raise Capital Without a Final Product

By Sabrina | 01/18/2026
How Smart Founders Raise Capital Without a Final Product Most HealthTech founders assume investor hesitation comes down to one thing: ... Read More

The Hidden Hiring Risks That Derail Fundraising Rounds

By Sabrina | 12/28/2025
The Hidden Hiring Risks That Derail Fundraising Rounds Most founders assume investors evaluate teams the same way LinkedIn does: credentials, ... Read More

Inside the Investor Roundtable: What AI Startups Keep Getting Wrong

By Sabrina | 12/28/2025
Inside the Investor Roundtable: What AI Startups Keep Getting Wrong Why deep tech isn't enough, and what FemTech, diagnostics, and ... Read More

Why Clinician-Trusted AI Outperforms: Integration, Retention, and Results

By Sabrina | 11/28/2025
Why Clinician-Trusted AI Outperforms: Integration, Retention, and Results AI models don't scale because they're smart. They scale because clinicians trust ... Read More

Don’t Bury the Lead: How to Package Your Proof So Investors Pay Attention (and Pay Up)

By Sabrina | 11/28/2025
Don't Bury the Lead: How to Package Your Proof So Investors Pay Attention (and Pay Up) When you have 10 ... Read More

What Do Investors Really Want to Hear in a FemTech or Diagnostic Pitch?

By Sabrina | 11/09/2025
What Do Investors Really Want to Hear in a FemTech or Diagnostic Pitch? Uncover how to turn your data and ... Read More

How Can Women’s Health Founders Translate Scientific Jargon Into Investor-Ready Messaging?

By Sabrina | 11/09/2025
How Can Women's Health Founders Translate Scientific Jargon Into Investor-Ready Messaging? Most founders believe their science should speak for itself. ... Read More

Protecting Wealth While Scaling a HealthTech Startup

By Sabrina | 11/09/2025
Protecting Wealth While Scaling a HealthTech Startup What Financial Systems Protect HealthTech Founders From Scaling Chaos and Personal Risk? When ... Read More